Skip to main content

Heinrich Dreismann and Harry Glorikian

In a filing with the US Securities and Exchange Commission, Interpace Diagnostics announced the resignations of Heinrich Dreismann and Harry Glorikian from the company's board of directors. The company stated that neither resignation was due to a disagreement with the company or matters relating to the company's operations, policies, or practices.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.